PerkinElmer, Inc.’s Acquisition Of SIRION BIOTECH GmbH

Hogan Lovells advised PerkinElmer, Inc. on the deal.

PerkinElmer, Inc. acquired SIRION BIOTECH GmbH, a leading global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is expected to close during the third quarter of 2021.

The addition of SIRION’s offerings will complement PerkinElmer’s Horizon Discovery portfolio which includes gene editing and modulation tools for CRISPR, CRISPRi and RNAi, custom cell lines for bio production and base editing technologies. Moreover, the acquisition will further broaden PerkinElmer’s existing cell and gene research solutions featuring industry-leading high content, in vivo, and cell painting screening technologies; innovative immunoassays; cell plate readers; and advanced automation, microfluidics and informatics and analytical platforms. 

Headquartered in Munich, privately held SIRION has approximately 50 employees based in Germany, the U.S. and France. The company has established a strong licensing portfolio leveraged by over a dozen major pharmaceutical and biotech players researching more than twenty five diseases and conditions. 

PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. 

The Hogan Lovells’ team inlcuded Dr. Lutz Angerer (Picture – Lead Partner, M&A, Munich), Guido Brockhausen (Lead Counsel, M&A, Dusseldorf), Andreas Thun (Counsel), Thomas Weber (Counsel), Dr. Thomas Richter (Senior Associate), Stephanie Brüggemann (Associate) (all M&A, Munich); Dr. Falk Loose (Counsel, Tax, Munich); Dr. Falk Schöning (Partner), Stefan Kirwitzke (Associate) (both Antitrust and Competition, Brussels) and Dr. Tim Joppich (Partner, Employment, Dusseldorf).

Involved fees earner: Lutz Angerer – Hogan Lovells; Guido Brockhausen – Hogan Lovells; Stephanie Brüggemann – Hogan Lovells; Tim Gero Joppich – Hogan Lovells; Stefan Kirwitzke – Hogan Lovells; Falk Loose – Hogan Lovells; Thomas Richter – Hogan Lovells; Falk Schöning – Hogan Lovells; Andreas Thun – Hogan Lovells; Thomas Weber – Hogan Lovells;

Law Firms: Hogan Lovells;

Clients: PerkinElmer Inc.;

Author: Federica Tiefenthaler